Cluster 1 - Health (Single stage - 2027/1)
Πηγή: EU Funds
📅 Λήξη υποβολής: 13/04/2027
📍 Περιφέρειες: Όλη η Ελλάδα
📋 Σε λίγα λόγια
Το πρόγραμμα αποσκοπεί στη μείωση των κινδύνων από ανεπιθύμητες αντιδράσεις φαρμάκων λόγω της χορήγησης πολλαπλών φαρμάκων. Δικαιούχοι είναι νομικά πρόσωπα από χώρες της ΕΕ και τρίτες χώρες που συμμετέχουν σε έργα του Horizon Europe, με δυνατότητα χρηματοδότησης που δεν αναφέρεται συγκεκριμένα. Η προθεσμία υποβολής λήγει το 2027 και το βασικό όφελος για τους δικαιούχους είναι η χρηματοδότηση για την ανάπτυξη καινοτόμων προσεγγίσεων στον τομέα της υγείας.
Περιγραφή προγράμματος
Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
<div class="eui-u-mt-l>"><h4>General conditions</h4><div><h4>1. Admissibility Conditions, proposal page limit and layout</h4><div class="eui-u-mt-s"><p>Admissibility conditions are <strong><em></em></strong>described in <a href="https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf" rel="noopener noreferrer" target="_blank">Annex A</a> and <a href="https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf" rel="noopener noreferrer" target="_blank">Annex E</a> of the Horizon Europe Work Programme General Annexes.</p><p>Proposal page limits and layout are described in Part B of the Application Form available in the Submission System.</p><p><br></br></p></div></div><div><h4>2. Eligible Countries</h4><div class="eui-u-mt-s"><p>Eligible countries are described in <a href="https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf" rel="noopener noreferrer" target="_blank">Annex B</a> of the Work Programme General Annexes.</p><p>A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the <a href="https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf" rel="noopener noreferrer" target="_blank">Horizon Europe Programme Guide</a>.</p><p><br></br></p></div></div><div><h4>3. Other Eligibility Conditions</h4><div class="eui-u-mt-s"><p>In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.</p></div><div class="eui-u-mt-s"><p>If projects use satellite-based earth observation, positioning, navigation and/or related timing data and services, beneficiaries must make use of Copernicus and/or Galileo/EGNOS (other data and services may additionally be used).</p></div><div class="eui-u-mt-s"><p>Subject to restrictions for the protection of European communication networks.</p></div><div class="eui-u-mt-s"><p>Other eligibility conditions are described in <a href="https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf" rel="noopener noreferrer" target="_blank">Annex B</a> of the Work Programme General Annexes.</p><p><br></br></p></div></div><div><h4>4. Financial and operational capacity and exclusion</h4><div class="eui-u-mt-s"><p>Financial and operational capacity and exclusion are described in <a href="https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf" rel="noopener noreferrer" target="_blank">Annex C</a> of the Work Programme General Annexes.</p><p><br></br></p></div></div><div><h4>5a. Evaluation and award: Award criteria, scoring and thresholds</h4><div class="eui-u-mt-s"><p>Award criteria, scoring and thresholds are described in <a href="https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf" rel="noopener noreferrer" target="_blank">Annex D</a> of the Work Programme General Annexes.</p></div></div><div><h4>5b. Evaluation and award: Submission and evaluation processes</h4><div class="eui-u-mt-s"><p>The thresholds for each criterion will be 4 (Excellence), 4 (Impact) and 4 (Implementation). The cumulative threshold will be 12.</p></div><div class="eui-u-mt-s"><p>Submission and evaluation processes are described in <a href="https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf" rel="noopener noreferrer" target="_blank">Annex F</a> of the Work Programme General Annexes and the <a href="https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf" rel="noopener noreferrer" target="_blank">Online Manual</a>.</p></div></div><div><h4>5c. Evaluation and award: Indicative timeline for evaluation and grant agreement</h4><div class="eui-u-mt-s"><p>Indicative timeline for evaluation and grant agreement are described in <a href="https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf" rel="noopener noreferrer" target="_blank">Annex F</a> of the Work Programme General Annexes.</p><p><br></br></p></div></div><div><h4>6. Legal and financial set-up of the grants</h4><div class="eui-u-mt-s"><p>The granting authority may, up to 4 years after the end of the action, object to a transfer of ownership or to the exclusive licensing of results, as set out in the specific provision of Annex 5.</p></div><div class="eui-u-mt-s"><p>Legal and financial set-up of the grants are described in <a href="https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf" rel="noopener noreferrer" target="_blank">Annex G</a> of the Work Programme General Annexes.</p><p><br></br></p></div></div></div><div class="eui-u-mt-l"><h4>Specific conditions</h4> <div class="eui-u-mt-s"><p>Specific conditions are described in the specific topic of the Work Programme.</p><p><br></br></p></div></div><div class="eui-u-mt-l"><div class="eui-u-mt-s">
</div><h4>Application and evaluation forms and additional documents:</h4> <div class="eui-u-mt-s"><p><strong>Application and evaluation form templates</strong></p><p><a href="https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/af_he-ria-ia_en.pdf" rel="noopener noreferrer" target="_blank">Standard application form (HE RIA, IA)</a> - the application form specific to this call is available in the Submission System</p><p><a href="https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/ef/ef_he-ria-ia_en.pdf" rel="noopener noreferrer" target="_blank">Standard evaluation form (HE RIA, IA)</a> - will be used with the necessary adaptations</p><p><strong>Guidance</strong></p><p><a href="https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf" rel="noopener noreferrer" target="_blank">HE Programme Guide</a></p><p><strong>Model Grant Agreement (MGA)</strong></p><p><a href="https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/agr-contr/general-mga_horizon-euratom_en.pdf" rel="noopener noreferrer" target="_blank">HE MGA</a></p><p><strong>Call-specific instructions</strong> </p><p><a href="https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/information-on-clinical-studies_he_en.docx" rel="noopener noreferrer" target="_blank">Information on clinical studies (HE)</a></p></div><h4>Additional documents</h4> <div class="eui-u-mt-s"><p><a href="https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-1-general-introduction_horizon-2026-2027_en.pdf" rel="noopener noreferrer" target="_blank">HE Main Work Programme 2026-2027 – 1. General Introduction</a></p><p><a href="https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-4-health_horizon-2026-2027_en.pdf" rel="noopener noreferrer" target="_blank">HE Main Work Programme 2026-2027 – 4. Health</a></p><p><a href="https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf" rel="noop
Επίσημη πηγή: EU Funds →
Παρόμοια προγράμματα
Call for applications: FRONTIERS Science Journalism Residency Program (Call 4)
EU Funds · έως 6.000 € · λήγει 25/05/2026
Open Call for innovative projects enhancing the valorisation of agri-food biomass
EU Funds · έως 90.000 € · λήγει 26/05/2026
EURES Targeted Mobility Scheme (TMS)
EU Funds · λήγει 26/05/2026
TASC-RestoreMed Open Call Type B: Transition Agenda Development (TAD)
EU Funds · λήγει 27/05/2026
Generic simulation models for climate suitability analysis of new and emerging plant pests
EU Funds · λήγει 27/05/2026
Τελευταία ενημέρωση: 24/05/2026